HealthEquity, Inc. $HQY Shares Sold by Motley Fool Asset Management LLC

Key Points

• Motley Fool Asset Management cut its HealthEquity stake by 16.7% in the third quarter, selling 15,501 shares and retaining 77,542 shares valued at approximately $6.86 million.
• Institutional ownership remains very high at 99.55%, with major investors including BlackRock, Wasatch Advisors, William Blair, Dimensional Fund Advisors, and Bank of America holding significant positions.
• Analyst sentiment is largely positive, with a consensus rating of “Moderate Buy” and an average price target of $113.53. HealthEquity also exceeded quarterly earnings and revenue estimates, reporting $1.24 EPS and $350.73 million in revenue.

Motley Fool Asset Management LLC decreased its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 16.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 77,542 shares of the company's stock after selling 15,501 shares during the quarter. Motley Fool Asset Management LLC's holdings in HealthEquity were worth $6,859,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. BlackRock Inc. bought a new stake in shares of HealthEquity in the 2nd quarter valued at about $1,018,621,000. Wasatch Advisors LP raised its position in shares of HealthEquity by 10.5% in the 2nd quarter. Wasatch Advisors LP now owns 7,960,735 shares of the company's stock valued at $719,014,000 after acquiring an additional 757,801 shares during the period. William Blair Investment Management LLC acquired a new stake in shares of HealthEquity in the 2nd quarter valued at approximately $160,158,000. Dimensional Fund Advisors LP boosted its stake in HealthEquity by 2.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,627,039 shares of the company's stock worth $135,957,000 after acquiring an additional 45,287 shares during the last quarter. Finally, Bank of America Corp DE bought a new position in HealthEquity during the 2nd quarter worth approximately $103,573,000. Institutional investors own 99.55% of the company's stock.

Analyst Upgrades and Downgrades

HQY has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of HealthEquity from $135.00 to $142.00 and gave the company a "buy" rating in a report on Monday, August 31st. Citigroup reiterated a "market outperform" rating on shares of HealthEquity in a report on Friday, August 28th. Wall Street Zen upgraded shares of HealthEquity from a "hold" rating to a "buy" rating in a research report on Saturday, October 10th. Weiss Ratings raised HealthEquity from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Friday, October 16th. Finally, Telsey Advisory Group set a $111.00 price objective on HealthEquity in a research note on Friday, August 28th. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $113.53.

HealthEquity Price Performance

NASDAQ HQY opened at $101.34 on Thursday. The business has a 50 day simple moving average of $95.46 and a 200 day simple moving average of $88.91. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $107.62. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.99 and a current ratio of 2.99. The stock has a market cap of $8.38 billion, a price-to-earnings ratio of 36.58, a PEG ratio of 1.64 and a beta of 0.24.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its earnings results on Thursday, August 27th. The company reported $1.24 EPS for the quarter, topping the consensus estimate of $1.19 by $0.05. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. The firm had revenue of $350.73 million for the quarter, compared to the consensus estimate of $349.22 million. HealthEquity's revenue for the quarter was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. Analysts anticipate that HealthEquity, Inc. will post 3.93 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Adrian Dillon sold 7,632 shares of the firm's stock in a transaction on Tuesday, August 25th. The shares were sold at an average price of $104.61, for a total transaction of $798,383.52. Following the sale, the director directly owned 62,395 shares in the company, valued at $6,527,140.95. This trade represents a 10.90% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.60% of the stock is owned by corporate insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled benefits administration and financial services that help employers and individuals manage tax-advantaged healthcare accounts. The company's offerings include health savings accounts (HSAs), flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), and other consumer-directed benefits.

In addition to account administration, HealthEquity provides payment cards, investment options for eligible account holders, employee engagement tools, and digital platforms for managing healthcare benefits.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.